• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCEL-SCI
    Picture of CEL-SCI logo

    CVM — CEL-SCI News Story

    $1.110.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $19.40m
    • Enterprise Value
      $24.35m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CVM Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CVM Dividends
    All News

    Amex Resumed Cel: SCI CORP ORD

    Picture of CEL-SCI logoCEL-SCI
    27/01/2021 16:52
    AMEX RESUMED CEL-SCI CORP ORD  CVM.A
    

    Recent news on CEL-SCI

    See all news
    • Brief: CEL-SCI Announces Closing Of Offering

      16/06/2026 21:14
    • Brief: Cel-Sci Corp Files For Offering Of 6 Million Shares Of Common Stock- SEC Filing

      13/05/2026 11:07
    • Brief: Cel-Sci Corporation Announces Pricing Of Public Offering

      12/05/2026 01:11
    • Brief: CEL-SCI Enters Strategic Agreement With Amarox For The Registration, Commercialization, And Distribution Of Multikine In Saudi Arabia

      11/05/2026 13:54
    • Drug developer CEL-SCI dives on deep-discounted equity raise

      28/08/2025 11:16

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.